Study Links a Novel Biomarker with Potential to Predict and Treat Skin Cancer Metastasis (IMAGE)

Elsevier

Study Links a Novel Biomarker with Potential to Predict and Treat Skin Cancer Metastasis

Caption

A new study in The American Journal of Pathology identifies C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.

Credit

The American Journal of Pathology / Heiskanen et al.

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.